SCHEMBL26316100

SCHEMBL26316100

COc1cc(C)ccc1-c1ccc(C)nn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.47
L3MBTL1 Q9Y468 3/20 0.42
MAPT P10636 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOB P27338 2/20 0.40
HSP90AA1 P07900 2/20 0.40
HSP90AB1 P08238 1/20 0.40
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CRHR1 P34998 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
KDM4E B2RXH2 1/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22296047 0.81 KDM4E (0.44) ACHEL3MBTL1MAPTALDH1A1HTT
SCHEMBL26316119 0.80 L3MBTL1 (0.41) ACHEL3MBTL1MAPTALDH1A1HTT
SCHEMBL26316117 0.80 ACHE (0.41) ACHEL3MBTL1MAPTALDH1A1HTT
SCHEMBL25400896 0.80 TP53 (0.48) HSP90AA1HSP90AB1CRHR1
SCHEMBL31399815 0.80 TP53 (0.48) HSP90AA1HSP90AB1CRHR1
SCHEMBL26316121 0.77 ALPL (0.45) ACHEL3MBTL1MAPTALDH1A1HTT
SCHEMBL9938324 0.77 ACHE (0.68) ACHEL3MBTL1MAPTALDH1A1SMN1; SMN2
SCHEMBL12270031 0.75 CCR1 (0.48) ACHEALDH1A1HSP90AA1HSP90AB1CYP3A4
SCHEMBL22434766 0.73 ACHE (0.44) ACHEL3MBTL1MAPTALDH1A1MAOB
SCHEMBL6015608 0.72 MAPT (0.56) L3MBTL1MAPTALDH1A1HTTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295113-A1 NLRP3 MODULATORS ZOMAGEN BIOSCIENCES LTD 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295113-A1 NLRP3 MODULATORS NLRP3, NLRP1, NOD1 ACHE 4865/4885L3MBTL1 1784/4885MAPT 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.